Oxysterols, but not cholesterol, inhibit human immunodeficiency virus replication in vitro. 1998

C Moog, and A M Aubertin, and A Kirn, and B Luu
INSERM U74, Institut de Virologie, Strasbourg, France. c.moog@viro-ulp.u-strasbg.fr

Oxysterols, oxygenated derivatives of cholesterol selected for their cytostatic activity and their inhibitory effect on cholesterol synthesis, have been investigated for their anti-human immunodeficiency virus (HIV) activity in vitro. The three oxysterols tested, 7 beta-hydroxycholesterol (7 beta-OHC), 25-hydroxycholesterol (25-OHC) and 7 beta, 25-dihydroxycholesterol (7,25-OHC), inhibit viral replication at micromolar concentrations. The selectivity indexes for 7 beta-OHC and 25-OHC are quite modest (2 to 8) but reproducible; the dihydroxycholesterol 7,25-OHC exhibited antiviral properties at concentrations 13- to 25-fold lower than the highest concentration tested at which no toxicity was measurable. Oxysterols are naturally occurring compounds, and we speculate on their physiological relevance in HIV-infected individuals.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D011533 Proviruses Duplex DNA sequences in eukaryotic chromosomes, corresponding to the genome of a virus, that are transmitted from one cell generation to the next without causing lysis of the host. Proviruses are often associated with neoplastic cell transformation and are key features of retrovirus biology. Provirus
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006888 Hydroxycholesterols Cholesterol which is substituted by a hydroxy group in any position.
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

C Moog, and A M Aubertin, and A Kirn, and B Luu
November 1994, AIDS research and human retroviruses,
C Moog, and A M Aubertin, and A Kirn, and B Luu
November 1990, The Journal of clinical investigation,
C Moog, and A M Aubertin, and A Kirn, and B Luu
February 1999, Pharmacotherapy,
C Moog, and A M Aubertin, and A Kirn, and B Luu
February 1990, Antimicrobial agents and chemotherapy,
C Moog, and A M Aubertin, and A Kirn, and B Luu
September 2006, Hepatology (Baltimore, Md.),
C Moog, and A M Aubertin, and A Kirn, and B Luu
January 2011, Bioorganic & medicinal chemistry letters,
C Moog, and A M Aubertin, and A Kirn, and B Luu
May 2003, Antiviral research,
C Moog, and A M Aubertin, and A Kirn, and B Luu
October 1987, The Journal of experimental medicine,
C Moog, and A M Aubertin, and A Kirn, and B Luu
March 1990, AIDS research and human retroviruses,
C Moog, and A M Aubertin, and A Kirn, and B Luu
January 1992, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!